TIAN CHANG GP Subsidiary Orders HK$54.50 Million Worth of JSW Magnesium Injection Molding Machines

Bulletin Express
昨天

Hong Kong, 16 September 2026 – Tian Chang Group Holdings Ltd. (TIAN CHANG GP) announced that its indirect wholly owned unit, Tian Hao New Materials Technology (Hui Zhou) Ltd. (the “Huizhou Subsidiary”), has placed a purchase order with Hong Kong-based Jie Long Foreign Trade Co., Ltd., the authorised agent of The Japan Steel Works (JSW), for 10 “JSW” brand magnesium injection molding machines (“Machinery”).

The all-in consideration totals JPY 1.09 billion (approximately HK$54.50 million), inclusive of import tariffs of JPY 66.50 million (HK$3.30 million). Financing will be provided entirely from the Group’s internal resources.

Key commercial terms: • Payment schedule – 30% of the consideration is payable within two weeks of signing as a prepayment; the remaining 70% is due after delivery and installation. • Delivery – Equipment will be shipped in batches between February and April 2027, with a 12-month warranty commencing upon issuance of the final acceptance certificate.

Strategic rationale: Management expects the machinery to expand the Group’s advanced manufacturing solutions segment into Magnesium Thixomolding, enabling a wider product and service offering, lowering reliance on single product categories, and strengthening relationships with existing customers.

Regulatory context: The deal’s highest applicable percentage ratio exceeds 5% but remains below 25%, classifying the transaction as a “Discloseable Transaction” under Chapter 14 of the Hong Kong Listing Rules. Consequently, it requires public disclosure but not shareholder approval.

Counterparties: • Huizhou Subsidiary – Engaged in development and production of new material products, including recycled PET felt, now extending into magnesium Thixomolding technologies. • Vendor – Jie Long Foreign Trade Co., Ltd., 80% owned by Li Qiang, acts as JSW’s designated sales agent for magnesium injection molding machines and is regarded as an Independent Third Party to the Group.

The Board concluded that the purchase order is on normal commercial terms, fair and reasonable, and in the best interests of the Group and its shareholders.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10